PERCOF 6 MG/ML XPE CT FR VD AMB X 120 ML + COP
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004306450036 -
GGREM
508016801137411 -
Código de barras
7891317411909
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- LEVODROPROPIZINA
- Embalagem
- 6 MG/ML XPE CT FR VD AMB X 120 ML + COP
- Tipo de produto
- Similar
- Classe terapêutica
- R5D1 - ANTITUSSÍGENOS PUROS
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "PERCOF 6 MG/ML XPE CT FR VD AMB X 120 ML + COP",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": null,
"barcodes": [
"7891317411909"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508016801137411",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "PERCOF",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "6 MG/ML XPE CT FR VD AMB X 120 ML + COP",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "29.20",
"icms-12": "33.18",
"icms-17": "35.18",
"icms-18": "35.61",
"icms-19": "36.05",
"icms-20": "36.50",
"icms-21": "36.96",
"icms-22": "37.44",
"icms-23": "37.92",
"icms-17.5": "35.39",
"icms-19.5": "36.27",
"icms-20.5": "36.73",
"icms-22.5": "37.68",
"icms-12-alc": "29.63",
"icms-17-alc": "31.41",
"icms-18-alc": "31.79",
"icms-19-alc": "32.19",
"icms-20-alc": "32.59",
"icms-21-alc": "33.00",
"icms-22-alc": "33.42",
"icms-23-alc": "33.86",
"withoutTaxes": "26.07",
"icms-17.5-alc": "31.60",
"icms-19.5-alc": "32.39",
"icms-20.5-alc": "32.79",
"icms-22.5-alc": "33.64"
},
"pisCofinsList": "Negativa",
"substanceText": "LEVODROPROPIZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "39.17",
"icms-12": "44.51",
"icms-17": "47.19",
"icms-18": "47.77",
"icms-19": "48.36",
"icms-20": "48.96",
"icms-21": "49.58",
"icms-22": "50.22",
"icms-23": "50.87",
"icms-17.5": "47.47",
"icms-19.5": "48.65",
"icms-20.5": "49.27",
"icms-22.5": "50.55",
"icms-12-alc": "40.96",
"icms-17-alc": "43.42",
"icms-18-alc": "43.95",
"icms-19-alc": "44.50",
"icms-20-alc": "45.05",
"icms-21-alc": "45.62",
"icms-22-alc": "46.20",
"icms-23-alc": "46.81",
"withoutTaxes": "36.04",
"icms-17.5-alc": "43.69",
"icms-19.5-alc": "44.78",
"icms-20.5-alc": "45.33",
"icms-22.5-alc": "46.51"
},
"invalidBarcodes": [],
"activeSubstances": [
"LEVODROPROPIZINA"
],
"therapeuticClass": "R5D1 - ANTITUSSÍGENOS PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004306450036",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "R5D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508016801137411"